Treatment of recurrent aphthous stomatitis with fumaric acid esters

Archives of Dermatology

Volumn 147, Issue 3, 2011, Pages 282-284

  Guenova, Emmanuella ^a   Hoetzenecker, Wolfram ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; CORTICOSTEROID; FUMARIC ACID DIMETHYL ESTER; FUMARIC ACID ETHYL ESTER; TRICLOSAN;

ADULT; APHTHOUS STOMATITIS; ARTICLE; CASE REPORT; CAUCASIAN; DRUG DOSE INCREASE; DRUG TOLERABILITY; FAMILY HISTORY; FEMALE; FLUSHING; GASTROINTESTINAL SYMPTOM; HUMAN; KIDNEY FUNCTION; LYMPHOCYTE COUNT; MOUTH ULCER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECURRENT DISEASE; SIDE EFFECT; TREATMENT OUTCOME; ULCER HEALING;

DRUG THERAPY, COMBINATION; FEMALE; FUMARATES; HUMANS; MIDDLE AGED; RECURRENCE; STOMATITIS, APHTHOUS;

EID: 79952842066     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.27     Document Type: Article

References (21)

1. Scully C, Porter S. Oral mucosal disease: recurrent aphthous stomatitis. Br J Oral Maxillofac Surg. 2008;46(3):198-206. (Pubitemid 351329434)
2. Femiano F, Lanza A, Buonaiuto C, et al. Guidelines for diagnosis and management of aphthous stomatitis. Pediatr Infect Dis J. 2007;26(8):728-732. (Pubitemid 47424644)
3. Porter S, Scully C. Aphthous ulcers (recurrent). Clin Evid. June 2005;(13):1687-1694.
4. Matthews RW, Scully CM, Levers BG, Hislop WS. Clinical evaluation of benzydamine, chlorhexidine, and placebo mouthwashes in the management of recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol. 1987;63(2):189-191. (Pubitemid 17016152)
5. Greer RO Jr, Lindenmuth JE, Juarez T, Khandwala A. A double-blind study of topically applied 5% amlexanox in the treatment of aphthous ulcers. J Oral Maxillofac Surg. 1993;51(3):243-249. (Pubitemid 23084196)
6. Hunter L, Addy M. Chlorhexidine gluconate mouthwash in the management of minor aphthous ulceration: a double-blind, placebo-controlled cross-over trial. Br Dent J. 1987;162(3):106-110.
7. Skaare AB, Herlofson BB, Barkvoll P. Mouthrinses containing triclosan reduce the incidence of recurrent aphthous ulcers (RAU). J Clin Periodontol. 1996;23(8):778-781. (Pubitemid 126732030)
8. Guggenheimer J, Brightman VJ, Ship II. Effect of chlortetracycline mouthrinses on the healing of recurrent aphthous ulcers: a double-blind controlled trial. J Oral Ther Pharmacol. 1968;4(5):406-408.
9. Stanley HR. Management of patients with persistent recurrent aphthous stomatitis and Sutton's disease. Oral Surg Oral Med Oral Pathol. 1973;35(2):174-179.
10. de Wazières B, Gil H, Magy N, Berthier S, Vuitton DA, Dupond JL. Treatment of recurrent ulceration with low doses of thalidomide: pilot study in 17 patients [in French]. Rev Med Interne. 1999;20(7):567-570.
11. Handfield-Jones S, Allen BR, Littlewood SM. Dapsone use with oral-genital ulcers. Br J Dermatol. 1985;113(4):501.
12. Chandrasekhar J, Liem AA, Cox NH, Paterson AW. Oxypentifylline in the management of recurrent aphthous oral ulcers: an open clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;87(5):564-567.
13. Ruah CB, Stram JR, Chasin WD. Treatment of severe recurrent aphthous stomatitis with colchicine. Arch Otolaryngol Head Neck Surg. 1988;114(6):671-675.
14. Lehner T, Wilton JM, Ivanyi L. Double blind crossover trial of levamisole in recurrent aphthous ulceration. Lancet. 1976;2(7992):926-929.
15. Boras VV, Lukac J, Brailo V, Picek P, Kordić D, Zilić IA. Salivary interleukin-6 and tumor necrosis factor-alpha in patients with recurrent aphthous ulceration. J Oral Pathol Med. 2006;35(4):241-243. (Pubitemid 43362956)
16. Borra RC, Andrade PM, Silva ID, et al. The Th1/Th2 immune-type response of the recurrent aphthous ulceration analyzed by cDNA microarray. J Oral Pathol Med. 2004;33(3):140-146. (Pubitemid 38250005)
17. Mrowietz U, Christophers E, Altmeyer P. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study: German Multicentre Study. Br J Dermatol. 1998;138(3):456-460. (Pubitemid 28145514)
18. Lehmann JC, Listopad JJ, Rentzsch CU, et al. Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1. J Invest Dermatol. 2007;127(4):835-845. (Pubitemid 46434667)
19. Rostami Yazdi M, Mrowietz U. Fumaric acid esters. Clin Dermatol. 2008;26(5):522-526.
20. Brewer L, Rogers S. Fumaric acid esters in the management of severe psoriasis. Clin Exp Dermatol. 2007;32(3):246-249. (Pubitemid 46495809)
21. Hoefnagel JJ, Thio HB, Willemze R, Bouwes Bavinck JN. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol. 2003;149(2):363-369. (Pubitemid 37100263)